Bajaj Finance share price falls 1.56% to ₹1,064.85 on November 9

Key Takeaways

• Bajaj Finance ended at ₹1,064.85, down 1.56%, and finished only ₹2.85 above the session low of ₹1,062.
• Nearly 9.89 million shares traded as the stock moved through a relatively compact ₹26 intraday range.
• The close remained above all three major moving averages, but the one-year return was marginally negative at 0.16%.

Bajaj Finance share price closed at ₹1,064.85 on November 9, falling ₹16.90 or 1.56%. It opened at ₹1,086, above the previous close of ₹1,082, and reached ₹1,088 at the session high. Selling later carried the price to ₹1,062. The stock ended only ₹2.85 above that low and ₹23.15 below the high, putting the close very near the lower end of its ₹26 day range. Trading volume reached 9,886,392 shares.

Despite the daily decline, Bajaj Finance remained above each of its reported moving averages. The 50-day DMA was ₹994.70, the 100-day DMA ₹998.30 and the 200-day DMA ₹985.30. The closing price was ₹70.15 above the 50-day level, ₹66.55 above the 100-day measure and ₹79.55 above the 200-day DMA.

The stock's 52-week low was ₹788 and its high was ₹1,176. The November 9 close was ₹276.85 above the low and ₹111.15 below the high. Market capitalisation stood at ₹6,62,971 crore. The annual range therefore remained much wider than the day's trading band, with the final price positioned considerably closer to the 52-week high than to the low in absolute rupee terms.

Recent returns were mixed. Bajaj Finance gained 11.39% over one month and 11.46% over six months, two figures separated by just 0.07 percentage point. Three-month performance was negative 1.22%, while the one-year figure was also slightly negative at 0.16%.

The November 9 close was distinguished by its proximity to the intraday low. The stock had begun above its prior close and traded as high as ₹1,088, but the final level was at the opposite end of the range. The moving-average position remained different from the day's direction, with the final price still above all three reported DMAs.